Thioredoxin reductase regulates AP-1 activity as well as thioredoxin nuclear localization via active cysteines in response to ionizing radiation

University of Maryland, Baltimore, Baltimore, Maryland, United States
Oncogene (Impact Factor: 8.46). 10/2002; 21(41):6317-27. DOI: 10.1038/sj.onc.1205749
Source: PubMed


A recently identified class of signaling factors uses critical cysteine motif(s) that act as redox-sensitive 'sulfhydryl switches' to reversibly modulate specific signal transduction cascades regulating downstream proteins with similar redox-sensitive sites. For example, signaling factors such as redox factor-1 (Ref-1) and transcription factors such as the AP-1 complex both contain redox-sensitive cysteine motifs that regulate activity in response to oxidative stress. The mammalian thioredoxin reductase-1 (TR) is an oxidoreductase selenocysteine-containing flavoprotein that also appears to regulate multiple downstream intracellular redox-sensitive proteins. Since ionizing radiation (IR) induces oxidative stress as well as increases AP-1 DNA-binding activity via the activation of Ref-1, the potential roles of TR and thioredoxin (TRX) in the regulation of AP-1 activity in response to IR were investigated. Permanently transfected cell lines that overexpress wild type TR demonstrated constitutive increases in AP-1 DNA-binding activity as well as AP-1-dependent reporter gene expression, relative to vector control cells. In contrast, permanently transfected cell lines expressing a TR gene with the active site cysteine motif deleted were unable to induce AP-1 activity or reporter gene expression in response to IR. Transient genetic overexpression of either the TR wild type or dominant-negative genes demonstrated similar results using a transient assay system. One mechanism through which TR regulates AP-1 activity appears to involve TRX sub-cellular localization, with no change in the total TRX content of the cell. These results identify a novel function of the TR enzyme as a signaling factor in the regulation of AP-1 activity via a cysteine motif located in the protein.

Download full-text


Available from: Junji Yodoi, May 02, 2014
  • Source
    • "In Schizosaccharomyces pombe, an oxidative stress signal can be transmitted to the SAPK/MAPK module independently of the phosphorelay system module suggesting a direct ROS activation mechanism on Wak1/Win1 MEKK or involvement of a novel zinc-finger transcription factor Hsr1 signaling circuit [20,21]. Several transcription factors such as AP-1 homologs and CCAAT-binding transcription factors (see below) can be directly engaged in signaling by redox stimulus [7,22] or by modulation of AP-1 activity with the involvement of the thioredoxin system [23,24]. This highly conserved regulatory network that includes signaling modules, transcription factors, and target genes provides a robust defense system against oxidative stress in yeast and filamentous fungi. "
    [Show abstract] [Hide abstract]
    ABSTRACT: There is extensive and unequivocal evidence that secondary metabolism in filamentous fungi and plants is associated with oxidative stress. In support of this idea, transcription factors related to oxidative stress response in yeast, plants, and fungi have been shown to participate in controlling secondary metabolism. Aflatoxin biosynthesis, one model of secondary metabolism, has been demonstrated to be triggered and intensified by reactive oxygen species buildup. An oxidative stress-related bZIP transcription factor AtfB is a key player in coordinate expression of antioxidant genes and genes involved in aflatoxin biosynthesis. Recent findings from our laboratory provide strong support for a regulatory network comprised of at least four transcription factors that bind in a highly coordinated and timely manner to promoters of the target genes and regulate their expression. In this review, we will focus on transcription factors involved in co-regulation of aflatoxin biosynthesis with oxidative stress response in aspergilli, and we will discuss the relationship of known oxidative stress-associated transcription factors and secondary metabolism in other organisms. We will also talk about transcription factors that are involved in oxidative stress response, but have not yet been demonstrated to be affiliated with secondary metabolism. The data support the notion that secondary metabolism provides a secondary line of defense in cellular response to oxidative stress.
    Toxins 04/2013; 5(4):683-702. DOI:10.3390/toxins5040683 · 2.94 Impact Factor
  • Source
    • "Several studies have observed an inactivation of transcription factors resulting from increased concentrations of ROS [93–95]. For example, it was shown that the complex AP-1 is a basic leucine zipper protein, which is highly sensitive to changes in redox environment due to a cysteine residue in the DNA-binding domain [96]. Gene expression profile studies performed using in vivo models have shown that OTA impairs the antioxidant defense system regulated by Nrf2 [47]. "
    [Show abstract] [Hide abstract]
    ABSTRACT: The in vitro and in vivo evidence compatible with a role for oxidative stress in OTA carcinogenicity has been collected and described. Several potential oxido-reduction mechanisms have been identified in the past. More recently, the possibility of a reduction of cellular antioxidant defense has been raised as an indirect source of oxidative stress. Consequences resulting from the production of oxidative stress are observed at different levels. First, OTA exposure has been associated with increased levels of oxidative DNA, lipid, and protein damage. Second, various biological processes known to be mobilized under oxidative stress were shown to be altered by OTA. These effects have been observed in both in vitro and in vivo test systems. In vivo, active doses were often within doses documented to induce renal tumors in rats. In conclusion, the evidence for the induction of an oxidative stress response resulting from OTA exposure can be considered strong. Because the contribution of the oxidative stress response in the development of cancers is well established, a role in OTA carcinogenicity is plausible. Altogether, the data reviewed above support the application of a threshold-based approach to establish safe level of dietary human exposure to OTA.
    Journal of Toxicology 06/2011; 2011(2):645361. DOI:10.1155/2011/645361
  • Source
    • "The rate of local recurrence is particularly high in women under the age of 40 (23.9% at 10 years) [6] but the reasons for this are unknown. The cytotoxicity of low linear energy transfer (LET) ionizing radiation is primarily mediated via the production of reactive oxygen species (ROS) and free radicals, leading to increased oxidative stress, lipid and protein peroxidation, DNA damage and cell death [7]. Redox buffering systems are often deregulated in cancer cells and can interfere with the effectiveness of ROS generated by radiotherapy [8] [9]. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Deregulated redox systems provide cancer cells protection from increased oxidative stress, such as that induced by ionizing radiation. Expression of the thioredoxin system proteins (thioredoxin, thioredoxin reductase and thioredoxin interacting protein) and downstream peroxiredoxins (I-VI), was examined in tumor specimens from early stage breast cancer patients, subsequently treated by breast conserving surgery and locoregional radiotherapy, to determine if redox protein expression is associated with clinical outcome. Nuclear and cytoplasmic expression was assessed using conventional immunohistochemistry on a tissue microarray of 224 tumors. High expression of cytoplasmic peroxiredoxin-I correlated with a greater risk of local recurrence (p=0.009). When nuclear and cytoplasmic expression patterns were combined, patients with low nuclear but high cytoplasmic expression of peroxiredoxin-I increased significance (p=0.005). Both were independent factors (p=0.006 and 0.003) from multivariate analysis. Associations were obtained between tumor grade and nuclear thioredoxin interacting protein (p=0.01) and with cytoplasmic expression of peroxiredoxin-V (p=0.007) but not with peroxiredoxin-I suggesting that the latter may exert influence via regulation of oxidative stress rather than via altering the tumor phenotype. Results highlight the potential of using redox protein expression, namely peroxiredoxin-I, to predict clinical outcome and support further studies to validate its usefulness as an independent prognostic, and potentially predictive, marker.
    Radiotherapy and Oncology 06/2011; 100(2):308-13. DOI:10.1016/j.radonc.2011.05.029 · 4.36 Impact Factor
Show more